• Citer

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

par Ardizzoni, Andrea;Boni, Luca;Tiseo, Marcello;Fossella, Frank V;Schiller, Joan H;Paesmans, Marianne ;Radosavljevic, Davorin;Paccagnella, Adriano;Zatloukal, P;Mazzanti, Paola;Bisset, Donald;Rosell, Rafael;CISCA (CISplatin versus CArboplatin) Meta-analysis Group,
Référence Journal of the National Cancer Institute, 99, 11, page (847-857)
Publication Publié, 2007-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.
Auteur:	Ardizzoni, Andrea; Boni, Luca; Tiseo, Marcello; Fossella, Frank V; Schiller, Joan H; Paesmans, Marianne; Radosavljevic, Davorin; Paccagnella, Adriano; Zatloukal, P; Mazzanti, Paola; Bisset, Donald; Rosell, Rafael; CISCA (CISplatin versus CArboplatin) Meta-analysis Group,
Informations sur la publication:	Journal of the National Cancer Institute, 99, 11, page (847-857)
Statut de publication:	Publié, 2007-06
Sujet CREF:	Cancérologie
MeSH keywords:	Antineoplastic Agents -- therapeutic use
	Carboplatin -- therapeutic use
	Carcinoma, Non-Small-Cell Lung -- drug therapy
	Cisplatin -- therapeutic use
	Humans
	Lung Neoplasms -- drug therapy
	Randomized Controlled Trials as Topic
	Survival Rate
	Treatment Outcome
Note générale:	Comparative Study
	Meta-Analysis
Langue:	Anglais
Identificateurs:	urn:issn:0027-8874
	info:doi/10.1093/jnci/djk196
	info:pii/99/11/847
	info:pmid/17551145